Elyakim et al. [27] found that hsa-mir-191 can trigger proliferation inhibition and apoptosis via up-regulating the expression of the target genes SOX4, IL1A and TMC7 in hepatocellular carcinoma. The gene discussed is IL1A; the disease is hepatocellular carcinoma.